Oral delivery of chemotherapeutic agents: background and potential of drug delivery systems for colon delivery

被引:13
作者
Schoener, C. A. [1 ]
Peppas, N. A. [1 ,2 ,3 ]
机构
[1] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA
[2] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA
[3] Univ Texas Austin, Coll Pharm, Austin, TX 78712 USA
基金
美国国家科学基金会;
关键词
Chemotherapeutics; Oral delivery; Carriers; Hydrogels; Smart polymer carriers; Hydrophobic; Hydrophilic; PH-SENSITIVE HYDROGELS; IN-VITRO; COMPLEXATION HYDROGELS; 5-AMINOSALICYLIC ACID; RESPONSIVE HYDROGELS; PLGA NANOPARTICLES; CONTROLLED-RELEASE; INSULIN DELIVERY; DOXORUBICIN; CAPECITABINE;
D O I
10.1016/S1773-2247(12)50081-X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Chemotherapy and the use of chemotherapeutic agents have become routine in first line defense in the battle against cancer. In its current state, chemotherapy has only advanced in terms of new drugs and modifying existing drugs, but there is still a need for improved delivery methods, particularly oral delivery. The oral delivery of chemotherapeutics could greatly change the common practice of using intravenous injections and ultimately provide improved patient care, comfort, reduction in healthcare costs, and reduction in side effects. We offer here a position paper on the importance of oral chemotherapeutic methods. We believe that using physiological cues and environments of the gastrointestinal tract and designing smart polymer carriers, the quest for oral drug delivery of chemotherapeutics may be achieved.
引用
收藏
页码:459 / 468
页数:10
相关论文
共 110 条
[1]  
Abraham Sindhu, 2007, Indian Journal of Pharmaceutical Sciences, V69, P24
[2]  
Aigner K.R., 2011, IND CHEMOTHERAPY INT
[3]  
Airley R., 2009, CANC CHEMOTHERAPY
[4]   Stimuli-responsive hydrogels - Drugs take control [J].
Alexander, Cameron .
NATURE MATERIALS, 2008, 7 (10) :767-768
[5]   Increase of doxorubicin sensitivity by doxorubicin-loading into nanoparticles for hepatocellular carcinoma cells in vitro and in vivo [J].
Barraud, L ;
Merle, P ;
Soma, E ;
Lefrançois, L ;
Guerret, S ;
Chevallier, M ;
Dubernet, C ;
Couvreur, P ;
Trépo, C ;
Vitvitski, L .
JOURNAL OF HEPATOLOGY, 2005, 42 (05) :736-743
[6]  
Bast R.C., 2000, Cancer Medicine, V5th
[7]   Novel Approach to Gorlin Syndrome: A Patient Treated With Oral Capecitabine [J].
Beach, Douglas F. ;
Somer, Robert .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (14) :E397-E401
[8]   Doxorubicin-loaded PLGA nanoparticles by nanoprecipitation:: preparation, characterization and in vitro evaluation [J].
Betancourt, Tania ;
Brown, Brandon ;
Brannon-Peppas, Lisa .
NANOMEDICINE, 2007, 2 (02) :219-232
[9]   The tolerability of multiple oral doses of Pulsincap(TM) capsules in healthy volunteers [J].
Binns, J ;
Stevens, HNE ;
McEwen, J ;
Pritchard, G ;
Brewer, FM ;
Clarke, A ;
Johnson, ES ;
McMillan, I .
JOURNAL OF CONTROLLED RELEASE, 1996, 38 (2-3) :151-158
[10]   Oral chemotherapeutic delivery: Design and cellular response [J].
Blanchette, J ;
Peppas, NA .
ANNALS OF BIOMEDICAL ENGINEERING, 2005, 33 (02) :142-149